ATE362764T1 - Methoden zur behandlung der herz arrhythmie - Google Patents
Methoden zur behandlung der herz arrhythmieInfo
- Publication number
- ATE362764T1 ATE362764T1 AT97946362T AT97946362T ATE362764T1 AT E362764 T1 ATE362764 T1 AT E362764T1 AT 97946362 T AT97946362 T AT 97946362T AT 97946362 T AT97946362 T AT 97946362T AT E362764 T1 ATE362764 T1 AT E362764T1
- Authority
- AT
- Austria
- Prior art keywords
- methods
- cardiac arrhythmia
- treating cardiac
- treating
- ikur
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/50—Organo-phosphines
- C07F9/53—Organo-phosphine oxides; Organo-phosphine thioxides
- C07F9/5333—Arylalkane phosphine oxides or thioxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/24—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/50—Organo-phosphines
- C07F9/53—Organo-phosphine oxides; Organo-phosphine thioxides
- C07F9/532—Cycloaliphatic phosphine oxides or thioxides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/28—Phosphorus compounds with one or more P—C bonds
- C07F9/50—Organo-phosphines
- C07F9/53—Organo-phosphine oxides; Organo-phosphine thioxides
- C07F9/5325—Aromatic phosphine oxides or thioxides (P-C aromatic linkage)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Electrotherapy Devices (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2935296P | 1996-10-31 | 1996-10-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE362764T1 true ATE362764T1 (de) | 2007-06-15 |
Family
ID=21848603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97946362T ATE362764T1 (de) | 1996-10-31 | 1997-10-29 | Methoden zur behandlung der herz arrhythmie |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US5969017A (de) |
| EP (1) | EP0948335B1 (de) |
| JP (1) | JP4227198B2 (de) |
| AT (1) | ATE362764T1 (de) |
| AU (1) | AU723693B2 (de) |
| CA (1) | CA2268942A1 (de) |
| DE (1) | DE69737752T2 (de) |
| WO (1) | WO1998018475A1 (de) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6531495B1 (en) | 1999-10-02 | 2003-03-11 | Aventis Pharma Deutschland Gmbh | 2′-Substituted 1,1′-biphenyl-2-carboxamides, processes for their preparation, their use as medicaments, and pharmaceutical preparations comprising them |
| AU7928700A (en) * | 1999-10-22 | 2001-04-30 | Jeffrey Hosenpud | A new use of levosimendan |
| MY125533A (en) | 1999-12-06 | 2006-08-30 | Bristol Myers Squibb Co | Heterocyclic dihydropyrimidine compounds |
| US6500457B1 (en) | 2000-08-14 | 2002-12-31 | Peirce Management, Llc | Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent |
| DE10059418A1 (de) | 2000-11-30 | 2002-06-20 | Aventis Pharma Gmbh | Ortho, meta-substituierte Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
| DE10060807A1 (de) | 2000-12-07 | 2002-06-20 | Aventis Pharma Gmbh | Ortho, ortho-substituierte stickstoffhaltige Bisarylverbindungen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
| DE10061876A1 (de) | 2000-12-12 | 2002-06-20 | Aventis Pharma Gmbh | Arylierte Furan- und Thiophencarbonsäureamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
| DE10121003A1 (de) | 2001-04-28 | 2002-12-19 | Aventis Pharma Gmbh | Anthranilsäureamide, Verfahren zur Herstellung, ihrer Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen |
| DE10128331A1 (de) | 2001-06-12 | 2002-12-19 | Aventis Pharma Gmbh | Anthranilsäureamide mit Heteroarylsulfonyl-Seitenkette, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltende pharmazeutische Zubereitungen |
| GB0315950D0 (en) | 2003-06-11 | 2003-08-13 | Xention Discovery Ltd | Compounds |
| US7772232B2 (en) | 2004-04-15 | 2010-08-10 | Bristol-Myers Squibb Company | Quinazolinyl compounds as inhibitors of potassium channel function |
| GB0412986D0 (en) | 2004-06-10 | 2004-07-14 | Xention Discovery Ltd | Compounds |
| US7576212B2 (en) | 2004-12-09 | 2009-08-18 | Xention Limited | Thieno[2,3-B] pyridines as potassium channel inhibitors |
| GB0525164D0 (en) | 2005-12-09 | 2006-01-18 | Xention Discovery Ltd | Compounds |
| GB0815784D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| GB0815782D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| GB0815781D0 (en) | 2008-08-29 | 2008-10-08 | Xention Ltd | Novel potassium channel blockers |
| GB201105659D0 (en) | 2011-04-01 | 2011-05-18 | Xention Ltd | Compounds |
| NO3175985T3 (de) | 2011-07-01 | 2018-04-28 | ||
| AU2013203252B2 (en) | 2012-01-27 | 2015-08-20 | Gilead Sciences, Inc. | Combination therapies using late sodium ion channel blockers and potassium ion channel blockers |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8412864D0 (en) * | 1984-05-19 | 1984-06-27 | Smith Kline French Lab | Chemical compounds |
| GB8722776D0 (en) * | 1987-09-28 | 1987-11-04 | Smith Kline French Lab | Chemical compounds |
| NZ234087A (en) * | 1989-06-19 | 1991-08-27 | Teikoku Hormone Mfg Co Ltd | 2-(3-aryloxy(2-hydroxy-propylamino))-2-methylpropyl- aminophenyl pyridazine derivatives |
| US5428031A (en) * | 1991-12-03 | 1995-06-27 | Merck & Co., Inc. | Methods of treating cardiac arrhythmia |
| HU214320B (hu) * | 1991-12-20 | 1998-03-02 | EGIS Gyógyszergyár Rt. | Eljárás új 3(2H)-piridazinon-származékok és ezeket tartalmazó gyógyszerkészítmények előállítására |
| US5506228A (en) * | 1995-02-23 | 1996-04-09 | Merck & Co., Inc. | 2,6-diaryl pyridazinones with immunosuppressant activity |
| US5670504A (en) * | 1995-02-23 | 1997-09-23 | Merck & Co. Inc. | 2,6-diaryl pyridazinones with immunosuppressant activity |
-
1997
- 1997-10-28 US US08/958,958 patent/US5969017A/en not_active Expired - Fee Related
- 1997-10-29 WO PCT/US1997/019647 patent/WO1998018475A1/en active IP Right Grant
- 1997-10-29 AT AT97946362T patent/ATE362764T1/de not_active IP Right Cessation
- 1997-10-29 JP JP52072898A patent/JP4227198B2/ja not_active Expired - Fee Related
- 1997-10-29 AU AU51548/98A patent/AU723693B2/en not_active Ceased
- 1997-10-29 CA CA002268942A patent/CA2268942A1/en not_active Abandoned
- 1997-10-29 EP EP97946362A patent/EP0948335B1/de not_active Expired - Lifetime
- 1997-10-29 DE DE69737752T patent/DE69737752T2/de not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002514189A (ja) | 2002-05-14 |
| DE69737752D1 (de) | 2007-07-05 |
| EP0948335A4 (de) | 2001-08-22 |
| CA2268942A1 (en) | 1998-05-07 |
| DE69737752T2 (de) | 2008-01-31 |
| AU5154898A (en) | 1998-05-22 |
| WO1998018475A1 (en) | 1998-05-07 |
| EP0948335B1 (de) | 2007-05-23 |
| JP4227198B2 (ja) | 2009-02-18 |
| EP0948335A1 (de) | 1999-10-13 |
| AU723693B2 (en) | 2000-08-31 |
| US5969017A (en) | 1999-10-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE362764T1 (de) | Methoden zur behandlung der herz arrhythmie | |
| EP0946183A4 (de) | Methoden zur behandlung der herzarrhythmie | |
| DE69727190D1 (de) | Herzschrittmachersystem mit Glättung der ventrikulären Schrittfrequenz während hoher Vorhofarrythmien | |
| DE69407785T2 (de) | Benzoylbenzofuranderivate zur behandlung von herzarrhythmia | |
| ATE411831T1 (de) | Mehrfach-signalmuster zum filtern von fernfeld-r- zacken | |
| ATE180175T1 (de) | System zur stabilisierung von herzarrhythmien in echtzeit | |
| DE69322592D1 (de) | Vorhof-Defibrillator zur verzögerten Synchronkorrektur von Herzrhythmus | |
| DE69631139D1 (de) | Vorrichtungen zur risikoverminderung von stasis im herzvorhof | |
| DE69532401D1 (de) | Kardioverter zur selektiven Unterdrückung atrialer Fibrillation | |
| DE69330012D1 (de) | Von vielfachen Parametern abhängiger, die Stimulationsfrequenz anpassender Herzschrittmacher | |
| AU2002232523A1 (en) | Pacing methods and devices for treating cardiac arrhythmias and fibrillation | |
| CA2275221A1 (en) | Side access "over the wire" pacing lead | |
| PT955880E (pt) | Metodo e aparelho para tratamento de arritmias cardiacas sem alvo discreto | |
| DE69431943T2 (de) | Herzschrittmacher, der die Stimulationsfrequenz aus dem Blutdruckverlauf während der Diastole ableitet | |
| ATE168025T1 (de) | Vorhof-defibrillator für die auswahl eines zeitintervalls zur vorgabe von herzrhythmuskorrektur | |
| DE69821667D1 (de) | Kardioverter zur Behandlung von Vorhofflattern | |
| DE69917758D1 (de) | Vorrichtung zur behandlung von vorhofsarrythmien | |
| ID23218A (id) | Metoda pengobatan gagal jantung | |
| DE69110937D1 (de) | Herzschrittmacher zur Beendung von Herzarrhythmia. | |
| DE60203318D1 (de) | Vorrichtung zur verringerung der wahrscheinlichkeit von vorhofflimmern | |
| DE69116327T2 (de) | Rechnungsverfahren des Escape-Intervalles, nach dem der Vorhof, im Falle von nicht-Depolarisation stimuliert werden muss | |
| DE60312723D1 (de) | Herzstimulation zur erweiterung der refraktärzeit des vorhofs | |
| EP0981391A4 (de) | Vorhoffolgender herzschrittmacher | |
| Touboul et al. | Retrograde conduction in complete atrioventricular block Study using His bundle recordings. | |
| SU1066599A1 (ru) | Способ стимул ции родовой де тельности |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |